Drugs

Vicoprofen is the brand name for an oral analgesic medication. It is prescribed for short-term management of acute pain, such as post-surgical pain or active cancer treatment, generally for less than ten days.1 Vicoprofen is a fixed-dose combination of hydrocodone bitartrate and ibuprofen. Hydrocodone bitartrate is a semi-synthetic opioid.2 Its immediate-release (IR) form is commercially
0 Comments
Chemical peels are a widely used procedure for the management of acne scars. Also known as chemexfoliation, chemical peels for acne scars involve applying one or more chemical agents, of variable strength, to the skin’s surface. The process creates a controlled chemical-induced injury to the skin. Wounding promotes epidermal and dermal regeneration and tissue remodelling
0 Comments
The term ‘morning sickness’ has been the phrase used to describe nausea and vomiting that is associated with pregnancy for roughly the past 200 years,1 but can be misleading, because ‘morning sickness’ can also occur at night, or any time of the day. Nausea and vomiting occur in up to 74% of pregnancies, with 50%
0 Comments
Researchers at Case Western Reserve University have developed an integrated clinical and CT-based AI nomogram (CIAIN) to predict which COVID-19 patients need a ventilator. CIANE can more precisely identify patients at an earlier disease presentation who may need intubation and invasive mechanical ventilation. The novel approach would decrease disease progression and mortality. The study included a
0 Comments
September 8, 2021 Audience: Health Professional, Pharmacy  September 08, 2021 — Wilmington, MA, Azurity Pharmaceuticals, Inc. (“Azurity”) is voluntarily recalling one lot of Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit (“Firvanq®”) to the consumer level, as some products in the affected lot have been found to incorrectly contain a First Omeprazole (FIRST-PPI)
0 Comments
toripalimab Treatment for Nasopharyngeal Carcinoma Coherus and Junshi Biosciences Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma SHANGHAI, China, and REDWOOD CITY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (“Coherus”, Nasdaq:
0 Comments
Treatment for Wilson’s Disease FDA Acceptance for Filing of New Drug Application (NDA) for Trientine Tetrahydrochloride (TETA 4HCl) for the treatment of Wilson’s Disease NDA supported by positive data from Phase 3 CHELATE clinical trial TETA 4-HCl previously granted Orphan Drug Designation for first-line treatment of Wilson’s Disease Paris, France – 02 September 2021 – Orphalan
0 Comments
FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced that the
0 Comments
Treatment for Bacterial Vaginosis Daré Bioscience Announces FDA Acceptance and Priority Review of New Drug Application for DARE-BV1 for the Treatment of Bacterial Vaginosis SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) accepted for filing
0 Comments
Receding gums are gums that have pulled away from the teeth, exposing their root surfaces. This leaves the teeth at risk of decay, infection, and loss. If the recession is severe, it can cause symptoms, such as tooth sensitivity, pain, or infection. Can this process of gum receding be reversed? The gums (gingiva) form the
0 Comments
CAMBRIDGE, Mass. & BEIJING, September 01, 2021–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that Brukinsa (zanubrutinib) has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM). “We are delighted by
0 Comments
tapinarof Treatment for Plaque Psoriasis, Atopic Dermatitis Dermavant Announces FDA Acceptance for Filing of New Drug Application (NDA) for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE) August 10, 2021 –Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today
0 Comments
palovarotene Treatment for Fibrodysplasia Ossificans Progressiva Ipsen Announces Withdrawal of Palovarotene NDA, Confirming Intention to Resubmit Following Additional Data Analyses Paris (France), Friday 13 August, 2021 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following very recent discussions with the U.S. Food and Drug Administration (FDA), withdrawal of the New Drug Application (NDA) for palovarotene. This
0 Comments
September 1, 2021 Audience: Consumer, Patient, Health Professional, Pharmacy This information is an update to the FDA Drug Safety Communication issued on February 4, 2021. FDA also previously communicated about the safety clinical trial with Xeljanz, Xeljanz XR (tofacitinib) in February 2019 and July 2019 What safety concern is FDA announcing? Based on a completed
0 Comments
FDA Approves Invega Hafyera (paliperidone palmitate) for Twice-Yearly Treatment for Adults with Schizophrenia TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic Invega Hafyera (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia
0 Comments
Beets, and in particular beetroot juice, are known to have many health benefits. For example, beets are great for your cardiovascular well-being.1 That is, eating this vegetable promotes a healthy heart and a good flow of blood throughout the body. Beets may also have some benefits for diabetes. Beets also have a high fibre content,
0 Comments
Tibsovo is the first and only targeted therapy approved for patients with previously treated IDH1-mutated cholangiocarcinoma BOSTON, Aug. 25, 2021 /PRNewswire/ — Servier Pharmaceuticals, a growing leader in oncology committed to bringing the promise of tomorrow to the patients we serve, announced today that the U.S. Food and Drug Administration (FDA) approved Tibsovo® (ivosidenib tablets)
0 Comments
Treatment for Bladder Cancer Sesen Bio Receives Complete Response Letter from FDA for Vicineum (oportuzumab monatox-qqrs) CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aug. 13, 2021– Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding
0 Comments
Treatment for Prevention of COVID-19 Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of Comirnaty in Individuals 16 and Older New Phase 3 data show booster (third) dose of Comirnaty induces significant SARS-CoV-2 neutralizing antibody titers and demonstrated a favorable safety and tolerability profile SARS-CoV-2 neutralizing
0 Comments
ATLANTA, Aug. 30, 2021 /PRNewswire/ — UCB announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Briviact (brivaracetam) CV tablets, oral solution, and injection to treat partial-onset seizures in patients as young as one month of age.2 This is the first time that the IV formulation of Briviact
0 Comments
Pulp is the soft mass of connective tissue that is located in the center of the tooth. Dental pulp also contains nerves and blood vessels to provide essential nutrients to keep the tooth healthy and working properly. A pulpectomy is the removal of pulp tissue from all parts of a tooth that has become irreversibly
0 Comments
PRINCETON, N.J.–(BUSINESS WIRE) August 20, 2021 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg every two weeks or 480 mg every four weeks (injection for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the adjuvant treatment of patients with urothelial carcinoma (UC) who are at
0 Comments
elamipretide Treatment for Barth Syndrome Stealth BioTherapeutics Submits Elamipretide New Drug Application to FDA for Treatment of Barth Syndrome BOSTON, Aug. 24, 2021 /PRNewswire/ – Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced the submission of a New Drug Application (NDA)
0 Comments
Treatment for Prevention of COVID-19 Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine Final blinded analysis of Phase 3 COVE study of the Moderna COVID-19 vaccine shows 93% efficacy; efficacy remains durable through six months after second dose CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aug. 25, 2021– Moderna, Inc. (Nasdaq: MRNA),
0 Comments
Neurapraxia is the mildest type of nerve injury.1 It is a common disorder of the peripheral nervous system – the system of nerves that function to relay information between the brain, spinal cord, and the rest of the body. A person with neurapraxia will experience a loss of motor and sensory function. These functions are
0 Comments
FDA Approves Korsuva (difelikefalin) Injection for the Treatment of Moderate-to-Severe Pruritus in Hemodialysis Patients STAMFORD, Conn. and ST. GALLEN, Switzerland, Aug. 23, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics (Nasdaq: CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has approved Korsuva (difelikefalin) for injection for the treatment of moderate-to-severe pruritus
0 Comments
Consuming cannabis products doesn’t have the same effects on the respiratory system as smoking it – but are edibles bad for your heart? Cannabis, which is derived from the hemp plant, is widely known for its psychoactive and anti-nausea properties.  The active ingredient in cannabis that is associated with these effects is delta-9-tetrahydrocannabinol (THC).  Cannabis
0 Comments